Skip to main content

IRADIMED CORP

corporate_fare Company Profile

IRADIMED CORP

IRMD·NASDAQ·Industrial Applications And Services·CIK 0001325618

IRADIMED CORPORATION develops, manufactures, markets, and distributes Magnetic Resonance Imaging (MRI) compatible medical devices and related accessories, disposables, and services. The company was originally incorporated in Oklahoma in 1992 as IRI Development, Inc., and merged into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014. IRADIMED is the sole known provider of a non-magnetic intravenous (IV) infusion pump system, the MRidium® 3870 MRI Compatible IV Infusion Pump System, which is specifically designed for safe use during MRI procedures and operates reliably in magnetic fields up to 15,000 gauss. This system, introduced in 2025, was the first infusion delivery system to address many dangers and problems associated with MRI procedures. Standard infusion pumps contain magnetic and electronic components that can cause radio frequency interference and are hazardous near MRI magnets. The patented MRidium 3870 system features a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and a touch screen user interface to safely and predictably deliver anesthesia and other critical care IV fluids during various MRI procedures. This solution ensures accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is crucial for critically ill patients requiring continuous medication and for children and infants needing sedation for immobility during scans. The MRidium 3870 IV Infusion Pump System includes the MRidium 3870 MRI Compatible IV Infusion Pump, a non-magnetic IV pole mounting system, a non-magnetic mobile IV pole stand, proprietary disposable IV tubing sets, and other options like a Remote Display Unit.

IRADIMED CORP (NASDAQ:IRMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors IRMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • IRADIMED Reports Strong Q1 Financials with Double-Digit Growth and Healthy Liquidity
  • IRADIMED Reports Strong Q1 Growth, Reaffirms 2026 Guidance, and Sees Strong Demand for New Product
  • iRadimed Reports Q1 Adjusted EPS of $0.49
  • Officer and Director Roger Susi Files Intent to Sell $9.87M in IRMD Stock, Continuing Recent Sales Pattern
  • IRADIMED Reports Strong 2025 Results with 14.4% Revenue Growth, Increased Dividend, and New Product Launch

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$83.81M
Net Income
$22.48M
Diluted EPS
$1.75
Op. Cash Flow
$24.95M
Free Cash Flow
$17.18M
Gross Profit
$64.32M
Operating Income
$26.15M
Cash & Equivalents
$51.16M
Debt / Equity
0.00×
Net Margin
26.8%
Shares Outstanding
12.78M sh
Source: 10-K · filed 2026-03-06 · accession 0001104659-26-024691
Browse all tickers starting with I →
$93.6
52-week range · as of 2026-05-01 $50.31 – $107.9
Market cap
$1.2B
Volume
175.2K (1.2× avg)
3-mo avg 143.4K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IRMD - Latest Insights

IRMD
May 01, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $87.15
Real-time Price: $93.60 info
Change: +$6.45 (+7%) info
Market Cap: $1.196B info
IRMD
May 01, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $83.00
Real-time Price: $93.60 info
Change: +$10.60 (+13%) info
Market Cap: $1.196B info
IRMD
May 01, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $83.00
Real-time Price: $93.60 info
Change: +$10.60 (+13%) info
Market Cap: $1.196B info
IRMD
Mar 06, 2026, 4:24 PM EST
Filing Type: 144
Importance Score:
9
Price at Filing: $98.72
Real-time Price: $93.60 info
Change: -$5.12 (-5%) info
Market Cap: $1.196B info
IRMD
Mar 06, 2026, 4:05 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $98.72
Real-time Price: $93.60 info
Change: -$5.12 (-5%) info
Market Cap: $1.196B info
IRMD
Feb 10, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $95.97
Real-time Price: $93.60 info
Change: -$2.37 (-2%) info
Market Cap: $1.196B info